Predicting delirium in critically Ill COVID-19 patients using EEG-derived data: a machine learning approach.

Publication date: Jul 23, 2025

Delirium is a severe and common complication among critically ill patients, particularly those with SARS-CoV-2 infection, contributing to increased morbidity and mortality. Early identification of at-risk patients is crucial for timely intervention and improved outcomes. This prospective observational cohort study explores the potential of electroencephalography (EEG) combined with machine learning (ML) models for predicting delirium in critically ill patients with SARS-CoV-2 infection. A stepwise modeling approach was applied, starting with the independent analysis of specific EEG variables to assess their predictive value. Subsequently, three ML models were developed using data from 70 patients (31 with delirium, 39 without): two relied solely on EEG data, while the third integrated demographic, clinical, laboratory, and EEG data. An additional model analyzed EEG data before and after delirium diagnosis in 11 patients. Several EEG features were identified as predictors of delirium, with increased theta activity emerging as the most consistent. The best EEG-only model achieved an area under the curve (AUC) of 0. 733 (sensitivity = 0. 645, specificity = 0. 692), indicating moderate predictive performance. Including demographic, clinical, and laboratory variables improved performance (AUC = 0. 825, sensitivity = 0. 613, specificity = 0. 795). The model analyzing EEG features before and after delirium diagnosis achieved the highest accuracy (AUC = 0. 950, sensitivity and specificity = 0. 818), reinforcing the value of EEG-based monitoring. EEG-based ML models show promise for predicting delirium in critically ill patients, with increased theta activity identified as a key predictor. However, their moderate AUC, sensitivity, and specificity highlight the need for further refinement.

Open Access PDF

Concepts Keywords
Covid COVID-19
Delirium Delirium
Electroencephalography EEG
Models ICU
Machine learning
SARS-CoV-2 infection

Semantics

Type Source Name
disease MESH delirium
disease MESH critically Ill
disease MESH COVID-19
pathway REACTOME SARS-CoV-2 Infection
disease MESH morbidity
disease IDO intervention
drug DRUGBANK Coenzyme M
drug DRUGBANK Fosfomycin
disease IDO blood
disease MESH severe acute respiratory syndrome
disease MESH respiratory failure
disease MESH Confusion
drug DRUGBANK Trestolone
disease MESH neurodegenerative diseases
pathway REACTOME Neurodegenerative Diseases
disease MESH abnormalities
disease MESH seizures
disease MESH postoperative delirium
drug DRUGBANK Sevoflurane
drug DRUGBANK Albendazole
disease IDO history
disease MESH psychiatric disorders
disease MESH hypertension
disease MESH diabetes mellitus
disease MESH obesity
disease MESH dyslipidemia
disease MESH ischemic heart disease
disease MESH congestive heart failure
disease MESH pulmonary hypertension
disease MESH stroke
disease MESH cancers
disease MESH liver disease
disease MESH Parkinson’s disease
disease MESH schizophrenia
disease MESH multiple sclerosis
disease MESH amyloidosis
drug DRUGBANK Alkaline Phosphatase
drug DRUGBANK Creatinine
drug DRUGBANK Urea
drug DRUGBANK Fibrinogen Human
drug DRUGBANK Midazolam
drug DRUGBANK Oxazepam
disease IDO symptom
drug DRUGBANK Gold
disease IDO quality
disease MESH Coma
disease MESH complications

Original Article

(Visited 2 times, 1 visits today)